Safety and efficacy of Daclatasvir and Asunaprevir combination therapy for hemodialyzed patients with chronic hepatitis C
Not Applicable
Completed
- Conditions
- hemodialyzed patients with chronic hepatitis C
- Registration Number
- JPRN-UMIN000016355
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1 patients with heart failure 2 patients with decompensated cirrhosis 3 patients with allergic to NS5A inhibitor or HCV PI inhibitor 4 patients with HCC or other malignant disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method